Michael De Vivo
Company: BioXcel Therapeutics
Job title: Vice President, Neuroscience
Seminars:
Live Q&A 1:20 pm
day: Day One
BXCL501: Targeting Alpha2-Adrenrgic Receptors for Neuropsychiatric Symptoms 12:55 pm
• Stress activates Noradrenergic Signaling and may precipitate psychiatric symptoms • Alpha2-Adrenergic Receptors Regulate noradrenergic signaling • BXCL501 is designed to activate alpha2-adrenergic receptors and thereby alleviate the symptoms caused by overactive noradrenergic signaling • BXCL501 rapidly and effectively reduced agitation in patients with schizophrenia or bipolar disorderRead more
day: Day One